Senior advocate Harish Salve, appearing on behalf of Malvinder and Shivinder Singh told the Delhi High Court on Wednesday that Daiichi Sankyo had full knowledge of all affairs of Ranbaxy Laboratories while purchasing stake in the company in 2008. Highlighting ... Business Standard, 19 hours ago
India's generic drugmaking industry is getting wheeled out of intensive care. But is it really going home? The US Food and Drug Administration this week lifted the import ban on a factory that Mumbai-based Sun Pharmaceutical Industries inherited as part of ...The Financial Chronicle, 1 month ago
Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday that U.S. regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years. Sun gained the plant along with ...Sify, 1 month ago USFDA to lift import ban on Sun Pharma's Mohali plant Business Standard, 1 month ago
on your WebpageAdd Widget >Get your members hooked!